SEARCH

PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Showing posts with label amgen1. Show all posts
Showing posts with label amgen1. Show all posts

Thursday, April 30, 2015

wright3, wands, strahilevitz, amgen1

custom search

REVERSED
Tech Center 1700 Chemical & Materials Engineering
1722 Ex Parte Van Ingen Schenau et al 12000190 - (D) SMITH 112(1) Pillsbury Winthrop Shaw Pittman, LLP (NV) CHACKO DAVIS, DABORAH

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2461 Ex Parte Kuo 12420827 - (D) PYONIN 103 Blue Capital Law Firm, P.C. DUFFY, JAMES P

2485 Ex Parte Moore et al 13185395 - (D) FRANKLIN 112(2)/102/103 Vidas, Arrett & Steinkraus, P.A. VAS/Orbital ATK, Inc. LEE, Y YOUNG

Tech Center 2600 Communications
2641 Ex Parte Pridmore et al 11996230 - (D) BOUDREAU 102/103 41.50 112(2) NIXON PEABODY, LLP ZEWARI, SAYED T

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2811 Ex Parte Eisert et al 11684347 - (D) HANLON 103 FISH & RICHARDSON P.C. (BO) NADAV, ORI

2822 Ex Parte Vaartstra 11493967 - (D) TIMM 112(1)/103 Wells St. John P.S. PATTON, PAUL E

“[T]o be enabling, the specification of a patent must teach those skilled in the art how to make and use the full scope of the claimed invention without ‘undue experimentation.’” In re Wright, 999 F.2d 1557, 1561 (Fed. Cir. 1993)). “Whether undue experimentation is needed is not a single, simple factual determination, but rather is a conclusion reached by weighing many factual considerations.” In re Wands, 858 F.2d 731, 737 (Fed. Cir. 1988). The court in Wands set forth a number of factors to consider, i.e., (1) the quantity of experimentation necessary, (2) the amount of direction or guidance presented, (3) the presence or absence of working examples, (4) the nature of the invention, (5) the state of the prior art, (6) the relative skill of those in the art, (7) the predictability or unpredictability of the art, and (8) the breadth of the claims. Id. Although the Examiner need not review all the Wands factors as they are illustrative, not mandatory, the Examiner must “advance acceptable reasoning inconsistent with enablement.” In re Strahilevitz, 668 F.2d 1229, 1232 (CCPA 1982); Amgen, Inc. v. Chugai Pharm. Co., 927 F.2d 1200, 1213 (Fed.Cir.1991).

Here, the only evidence the Examiner relies upon is the breath of the claim as encompassing impossible or at least improbable chemical entities. But a statement that the claims are broad and encompass inoperative embodiments does not establish lack of enablement unless it is clear that the

experimentation needed to arrive at the usable zirconium/hafnium silicates within the formula was more than routine. The Examiner has not established that the experimentation needed was not routine, but undue.

We do not sustain the Examiner’s rejection under 35 U.S.C. § 112 ¶ 1 for lack of enablement.


Wright, In re, 999 F.2d 1557, 27 USPQ2d 1510 (Fed. Cir. 1993) 2107.01 ,   2161.01 ,   2164.03 ,   2164.01(a) ,   2164.04 ,   2164.05(a) ,   2164.06(b) ,   2164.08

Wands, In re, 858 F.2d 731, 8 USPQ2d 1400 (Fed. Cir. 1988) 706.03(a) ,   706.03(b) ,   2161.01 ,   2164.01 ,   2164.01(a) ,   2164.06 ,   2164.06(b)

Amgen, Inc. v. Chugai Pharmaceutical Co., 927 F.2d 1200, 18 USPQ2d 1016 Fed. Cir. 1991) 2138 ,   2138.04 ,   2143.02 ,   2163 2163.02 ,   2164.08 ,   2165.04 ,   2173.05(b) ,   2411.01

2842 Ex Parte BROWN et al 12433270 - (D) KATZ 102 41.50 103 Faegre Baker Daniels LLP GOOGLE O NEILL, PATRICK

2862 Ex Parte Demos 13325695 - (D) SHAW 103 FISH & RICHARDSON P.C. (DC) NGHIEM, MICHAEL P

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3629 Ex Parte Horn et al 10939524 - (D) LORIN 103 SAP / FINNEGAN, HENDERSON LLP JASMIN, LYNDA C

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3745 Ex Parte Winter 11869040 - (D) STAICOVICI 103 CARLSON, GASKEY & OLDS/PRATT & WHITNEY PRAGER, JESSE M

3748 Ex Parte Crawley et al 11871701 - (D) BROWN 102 Barnes & Thornburg LLP (IN) TRAN, DIEM T

AFFIRMED–IN–PART
Tech Center 1600 Biotechnology and Organic Chemistry
1636 Ex Parte Hashimoto et al 12747826 - (D) JENKS 103 103 J-TEK LAW PLLC GALISTEO GONZALEZ, ANTONIO

Tech Center 2100 Computer Architecture and Software
2128 Ex Parte Druskin et al 12356562 - (D) MANTIS MERCADER 103 103 WesternGeco L.L.C. SAXENA, AKASH

2172 Ex Parte Taylor et al 11961352 - (D) KAMHOLZ 102/103 101 CRGO LAW STEVEN M. GREENBERG WRIGHT, ELIZABETH G

AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1712 Ex Parte Houck et al 11343172 - (D) WARREN 103 MARSHALL, GERSTEIN & BORUN LLP ROLLAND, ALEX A

1726 Ex Parte Noda et al 12808742 - (D) ROESEL 102/103 3M INNOVATIVE PROPERTIES COMPANY GRESO, AARON J

1731 Ex Parte Weibel 12307893 - (D) KRATZ 103 CURATOLO SIDOTI CO., LPA HIJJI, KARAM Y

1767 Ex Parte Shimono et al 11578066 - (D) HOUSEL 103 SUGHRUE MION, PLLC BUIE-HATCHER, NICOLE M

1772 Ex Parte LAURITZEN et al 12542400 - (D) SMITH 103 SHELL OIL COMPANY DANG, THUAN D

1789 Ex Parte Snider et al 11449265 - (D) GARRIS 103 Polymer Group, Inc. MATZEK, MATTHEW D

Tech Center 2100 Computer Architecture and Software
2197 Ex Parte Pena et al 11318802 - (D) KINDER 102 112(2)/103 CRGO LAW STEVEN M. GREENBERG COYER, RYAN D

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2453 Ex Parte Levi 12361279 - (D) ZADO 102 HEWLETT-PACKARD COMPANY KYLE, TAMARA TESLOVICH

2454 Ex Parte HUNG et al 12715559 - (D) BRANCH 102/103 CANTOR COLBURN LLP- BAKER HUGHES INCORPORATED LIN, WEN TAI

2476 Ex Parte WANG et al 11428964 - (D) SHIANG 103 Davidson Sheehan LLP Alcatel-Lucent USA Inc. SLOMS, NICHOLAS

2477 Ex Parte Soni et al 11656861 - (D) KRIVAK 102/103 Kilpatrick Townsend & Stockton LLP Adobe Systems YOUNG, STEVE R

2485 Ex Parte Thoreau et al 12223887 - (D) BRANCH 103 TUTUNJIAN & BITETTO, P.C. TORRENTE, RICHARD T

Tech Center 2600 Communications
2623 Ex Parte Lee et al 10911542 - (D) McMILLIN 103 ROYLANCE, ABRAMS, BERDO & GOODMAN, L.L.P. ZUBAJLO, JENNIFER L

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2881 Ex Parte Florin et al 12028884 - (D) SMITH 103 SIEMENS CORPORATION PURINTON, BROOKE J

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3622 Ex Parte Boss et al 10726186 - (D) BROWN 103 CAHN & SAMUELS, LLP DURAN, ARTHUR D

3626 Ex Parte Hyde et al 12286751 - (D) BARRETT 101 102/103 Constellation Law Group, PLLC LUBIN, VALERIE

3626 Ex Parte Hyde et al 12287686 - (D) BARRETT 101 103 Constellation Law Group, PLLC LUBIN, VALERIE

3657 Ex Parte Von Hayn et al 11997774 - (D) STAICOVICI 103 CONTINENTAL AUTOMOTIVE SYSTEMS, INC. SAHNI, VISHAL R

3671 Ex Parte MAHAL et al 12892945 - (D) KERINS 103 KILPATRICK TOWNSEND & STOCKTON LLP HARTMANN, GARY S

3681 Ex Parte Marhoefer 13506870 - (D) BROWN 102 101 41.50 112(2) L. Joseph Maroefer BRANDENBURG, WILLIAM A

3685 Ex Parte Perttila et al 10452865 - (D) HUTCHINGS 101 103 Ditthavong & Steiner, P.C. AGWUMEZIE, CHINEDU CHARLES

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3744 Ex Parte Lifson et al 12088022 - (D) KERINS 102/103 CARLSON, GASKEY & OLDS, P.C. BRADFORD, JONATHAN

REEXAMINATION

REVERSED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3736 GLOBUS MEDICAL, INC. Requester and Appellant v. NUVASIVE, INC. Patent Owner and Respondent Ex Parte 7905840 et al 10/967,668 95001890 - (D) LEBOVITZ 103 41.77(b) 103 FISH & RICHARDSON P.C. (TC) WILLIAMS, CATHERINE SERKE original SMITH, FANGEMONIQUE A

AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1781 E. I. DU PONT DE NEMOURS AND COMPANY Requester and Cross Appellant v. MONSANTO COMPANY Patent Owner and Appellant Ex Parte 8,057,835 et al 11/267,540 95002309 - (D) GUEST 102/103 DENTONS US LLP THIRD-PARTY REQUESTER: Dickstein Shapiro, LLP DIAMOND, ALAN D original PADEN, CAROLYN A

REHEARING

DENIED
3303 REFOCUS OCULAR, INC. Requester, Respondent v. READING ENHANCEMENT CO. Patent Owner, Appellant Ex Parte 7,736,389 B1 et al 07/712,359 95002082 - (D) MARTIN NGHIEM, MICHAEL P Edwin H. Crabtree REQUESTER: WILLIAM A. MUNCK, ESQ. FLANAGAN, BEVERLY MEINDL original SMITH, JEFFREY A

DENIED
3303 REFOCUS OCULAR, INC. Requester, Respondent v. READING ENHANCEMENT CO. Patent Owner, Appellant Ex Parte 8,167,938 B1 et al 95002083 - (D) MARTIN FISH & RICHARDSON P.C. (DC) Edwin H. Crabtree REQUESTER: WILLIAM A. MUNCK, ESQ. FLANAGAN, BEVERLY MEINDL original SMITH, JEFFREY A

Tuesday, September 24, 2013

amgen1

custom search

REVERSED
2163 Ex Parte Adema et al 10609981 - (D) COURTENAY 102/103 STREETS & STEELE - IBM CORPORATION PHAN, TUANKHANH D

2177 Ex Parte Hopkins 10287177 - (D) DILLON 103 37 CFR 40.51(b) 103 SALESFORCE.COM, INC. TRAN, QUOC A

2447 Ex Parte Parry 10144922 - (D) DILLON 103 HEWLETT-PACKARD COMPANY TANG, KAREN C

2678 Ex Parte Imamura 11592248 - (D) ANDERSON 102 NIXON & VANDERHYE, P.C. BRIER, JEFFERY A

2895 Ex Parte Doris et al 10710272 - (D) WHITEHEAD, JR. 103 MCGINN INTELLECTUAL PROPERTY LAW GROUP, PLLC TSAI, H JEY

3628 Ex Parte Sharp 10292686 - (D) CRAWFORD 102(e) CAREY, RODRIGUEZ, GREENBERG & O'KEEFE, LLP CAMPBELL, SHANNON S

3628 Ex Parte Milanes Garcia-Moreno 10472221 - (D) CRAWFORD 103 ROYLANCE, ABRAMS, BERDO & GOODMAN, L.L.P. BORISSOV, IGOR N

3651 Ex Parte Christie 11745262 - (D) SAINDON 103 HEWLETT-PACKARD COMPANY BURGESS, RAMYA PRAKASAM

3695 Ex Parte Kim et al 09837291 - (D) CRAWFORD 102(e)/103 LOWE HAUPTMAN & HAM, LLP OYEBISI, OJO O

3768 Ex Parte Poland 11911121 - (D) SCHEINER 102 PHILIPS INTELLECTUAL PROPERTY & STANDARDS EVOY, NICHOLAS LANE

3773 Ex Parte Schmieding et al 11155742 - (D) FREDMAN 103 DICKSTEIN SHAPIRO LLP MASHACK, MARK F

3726 Ex Parte Naumann 11522104 - (D) HILL 102 PROSKAUER ROSE LLP CIGNA, JACOB JAMES 

AFFIRMED-IN-PART
3774 Ex Parte Meyer et al 11873058 - (D) SPAHN 102(e) 102(e) VIDAS, ARRETT & STEINKRAUS, P.A. STEWART, ALVIN J

AFFIRMED
1637 Ex Parte Nurmi et al 10579137 - (D) JENKS 102(e) JAMES C. LYDON MUMMERT, STEPHANIE KANE

1658 Ex Parte Tovi et al 11416856 - (D) JENKS 103 KENYON & KENYON LLP NIEBAUER, RONALD T

1734 Ex Parte Wolf et al 11752403 - (D) PAK 103 NOVAK DRUCE CONNOLLY BOVE + QUIGG LLP NGUYEN, NGOC YEN M

1761 Ex Parte Nappa et al 12517577 - (D) KRATZ 103 E I DU PONT DE NEMOURS AND COMPANY HARDEE, JOHN R

1763 Ex Parte Kish et al 11343099 - (D) DELMENDO 112(2)/103 102(b)/102(e)/103 CHRISTOPHER JOHN RUDY AHVAZI, BIJAN

The mere fact that the term “about” permits some tolerance does not, in and of itself, support a rejection under 35 U.S.C. § 112, ¶ 2. In this case, the Examiner failed to explain why one skilled in the relevant art would not have been able to ascertain the scope of the claim in view of the recited term “about.” Amgen, Inc. v. Chugai Pharm. Co., Ltd, 927 F.2d 1200, 1218 (Fed. Cir. 1991) (holding that a specific activity of “at least about 160,000” was indefinite where the scope of the limitation was in doubt, “especially when . . . there is close prior art,” but cautioning that the holding “should not be understood as ruling out any and all uses of this term in patent claims”).

Amgen, Inc. v. Chugai Pharmaceutical Co., 927 F.2d 1200, 18 USPQ2d 1016 Fed. Cir. 1991) 2138, 2138.04, 2143.02, 2163, 2163.02, 2164.08, 2165.04, 2173.05(b), 2411.01
HARMON 4: 98; 5: 9, 28, 37, 59, 81, 91, 97, 116, 269, 280; 12: 277; 18: 152; 19: 476; 20: 176, 241
DONNER 4: 30, 44, 59, 64, 65, 69; 5: 129, 140, 142; 7: 338; 8: 647; 9: 156, 507, 718, 719, 723, 881, 884-86; 10: 127, 541

1776 Ex Parte Beall et al 11895312 - (D) KIMLIN 103 CORNING INCORPORATED ORLANDO, AMBER ROSE

2159 Ex Parte Lewis et al 10907483 - (D) SAADAT 102(e)/103 Fogg & Powers LLC BLACK, LINH

2166 Ex Parte Chatterjee et al 10600390 - (D) BRANCH 103 IBM CORPORATION HARPER, ELIYAH STONE

2168 Ex Parte Wang et al 11540038 - (D) DANG 102 HICKMAN PALERMO TRUONG BECKER BINGHAM WONG/ORACLE KIM, CHONG R

2171 Ex Parte Malone et al 11741511 - (D) FRANKLIN 103 HEWLETT-PACKARD COMPANY SALOMON, PHENUEL S

2194 Ex Parte Lucas 11260794 - (D) DANG 102/103 RSW IPLAW/SEB IBM CORPORATION DAO, TUAN C.

2427 Ex Parte Sandoval 11257098 - (D) DILLON 102(e)/103 Great Lakes Intellectual Property, PLLC /CableLabs ALATA, YASSIN

2438 Ex Parte Thomson 11342774 - (D) BENOIT 102/103 CAREY, RODRIGUEZ, GREENBERG & O'KEEFE, LLP CHANG, KENNETH W

2438 Ex Parte Jung et al 11526213 - (D) DANG 101/112(2)/103 Constellation Law Group, PLLC HERZOG, MADHURI R

2644 Ex Parte Buddhikot et al 11017997 - (D) McKONE 103 WALL & TONG, LLP/ALCATEL-LUCENT USA INC. CAI, WAYNE HUU

2646 Ex Parte Chang et al 11565438 - (D) DANG 112(1)/103 STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. GU, YU

2695 Ex Parte Altas et al 11731975 - (D) McKONE 112(1)/112(2) 102/103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS LAM, VINH TANG

2696 Ex Parte Kim et al 11588221 - (D) THOMAS 103 LOWE HAUPTMAN & HAM, LLP CRAWLEY, KEITH L

3637 Ex Parte Oberhaus et al 11325971 - (D) BUNTING 103 Paul M. Denk CHEN, JOSE V

REEXAMINATION

AFFIRMED
3625 SAP AMERICA, INC. Requestor, Cross-Appellant, Respondent v. ELCOMMERCE.COM, INC. Patent Owner, Appellant, Respondent 95000557 6947903 09/546,347 SAINDON 103 DOERRLER, WILLIAM CHARLES Third Party Requester:FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LL DOERRLER, WILLIAM CHARLES original SMITH, JEFFREY A